|
Volumn 22, Issue 14, 2012, Pages 4769-4772
|
Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors
|
Author keywords
ACC; Acetyl CoA carboxylase; Fatty acid oxidation; Obesity; Spiro pyrazolidinedione; Spiro pyrazolo 1,2 a pyridazine
|
Indexed keywords
ACETYL COENZYME A CARBOXYLASE;
BENZOTHIOPHENE;
ENZYME INHIBITOR;
PYRAZOLE DERIVATIVE;
PYRIDAZINE DERIVATIVE;
SPIRO PYRAZOLO[1,2 ALPHA]PYRIDAZINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CHIRALITY;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG STRUCTURE;
FATTY ACID OXIDATION;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
RAT;
RESPIRATORY QUOTIENT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ACETYL-COA CARBOXYLASE;
ANIMALS;
ENZYME INHIBITORS;
HUMANS;
MICROSOMES;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PYRAZOLES;
RATS;
SPIRO COMPOUNDS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
RATTUS;
|
EID: 84863428644
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.05.062 Document Type: Article |
Times cited : (40)
|
References (13)
|